Here are four things to know about his quest.
1. Mr. Bo’s group is seeking hospital deals in regions such as Australia, Singapore, Southeast Asia, the U.S. and Europe.
2. The group already owns a publicly traded pharmaceutical business, Luye Pharma Group, and agreed last year to a purchase an Australian hospital operator for $688 million, according to the report.
3. Now, Mr. Bo aims to introduce more international hospital brands into China, where public hospitals are overburdened by the increasing number of illnesses such as heart disease and diabetes, according to Bloomberg.
4. According to the report, if Mr. Bo’s group were to purchase established foreign brands, the group would be financially able to raise funds and bundle them later into an initial public offering.
More articles on transactions:
Uncertainty about buyer’s Medicare status delays sale of shuttered Texas hospital
6 recent hospital transactions and partnerships
Group Health approves $1.8B acquisition by Kaiser
